Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2008 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases.
J Cell Mol Med. 2023 Feb;27(3):322-339. doi: 10.1111/jcmm.17669. Epub 2023 Jan 18.
J Cell Mol Med. 2023.
PMID: 36651415
Free PMC article.
Review.
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP.
Ng EW, et al. Among authors: calias p.
Nat Rev Drug Discov. 2006 Feb;5(2):123-32. doi: 10.1038/nrd1955.
Nat Rev Drug Discov. 2006.
PMID: 16518379
Review.
Item in Clipboard
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.
Ju M, Mailhos C, Bradley J, Dowie T, Ganley M, Cook G, Calias P, Lange N, Adamis AP, Shima DT, Robinson GS.
Ju M, et al. Among authors: calias p.
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):662-70. doi: 10.1167/iovs.07-0195.
Invest Ophthalmol Vis Sci. 2008.
PMID: 18235012
Item in Clipboard
Cite
Cite